左心室辅助装置植入后肾脏功能的独特轨迹
研究基于INTERMACS注册数据,纳入2016至2017年美国成人连续流左心室辅助装置植入者共4615例,采用潜在类别混合模型分析植入前至约12个月的估算肾小球滤过率轨迹。识别出5种轨迹组,其中最大的两组占队列80%以上,另发现3种新轨迹组,各组基线特征与结局存在差异。
要点
- 共识别5种eGFR轨迹组,最大两组占队列80%以上,表现为早期上升后下降并稳定。
- 新轨迹组包括:持续低肾功能(10.1%)、持续改善(3.3%)、恶化后波动(1.7%)。
- 持续改善组更年轻且更多心源性休克和植入前透析;持续低肾功能组更多既存慢性肾病且年龄更大。
核心结论
- 在全国队列中识别出新的eGFR轨迹,可能代表不同的心肾过程。
- 1型心肾综合征可能在持续改善组中占主导,肾实质疾病可能在持续低肾功能组中占主导。
研究设计与样本
- 研究为队列研究,数据来自INTERMACS注册,纳入2016至2017年美国成人连续流左心室辅助装置植入共4615例。
- 主要结局为植入前至约12个月的估算肾小球滤过率轨迹,对主要样本和验证样本应用潜在类别混合模型。
主要发现
- 共识别5种eGFR轨迹组,最大的两组(第1组和第2组)占队列80%以上,与既往报道的平均轨迹相似,表现为早期eGFR上升后下降并稳定。
- 新轨迹组包括:恶化后持续低肾功能(第3组,10.1%)、持续改善(第4组,3.3%)、恶化后波动(第5组,1.7%)。
- 第4组更年轻且更多心源性休克和植入前透析;第3组既存慢性肾病比例更高且年龄更大。
- 各轨迹组在基线特征和结局上存在差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to assess for distinct kidney function trajectories following left ventricular assist device (LVAD) placement. Cohort studies of LVAD recipients demonstrate that kidney function tends to increase early after LVAD placement, followed by decline and limited sustained improvement. Inter-individual differences in kidney function response may be obscured. METHODS: We identified continuous flow LVAD implantations in US adults (2016-2017) from INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). Primary outcomes were estimated glomerular filtration rate (eGFR) trajectories pre-implantation to ∼12 months. Latent class mixed models were applied to primary and validation samples. Clinical differences among trajectory groups were investigated. RESULTS: Among 4,615 LVAD implantations, 5 eGFR trajectory groups were identified. The 2 largest groups (Groups 1 and 2) made up >80% of the cohort, and were similar to group average trajectories previously reported, with early eGFR rise followed by decline and stabilization. Three novel trajectory groups were found: worsening followed by sustained low kidney function (Group 3, 10.1%), sustained improvement (Group 4, 3.3%), and worsening followed by variation (Group 5, 1.7%). These groups differed in baseline characteristics and outcomes. Group 4 was younger and had more cardiogenic shock and pre-implantation dialysis; Group 3 had higher rates of pre-existing chronic kidney disease, along with older age. CONCLUSIONS: Novel eGFR trajectories were identified in a national cohort, possibly representing distinct cardiorenal processes. Type 1 cardiorenal syndrome may have been predominant in Group 4, and parenchymal kidney disease may have been predominant in Group 3.
引用
- Walther CP, Benoit JS, Lamba HK, et al. Distinctive kidney function trajectories following left ventricular assist device implantation. J Heart Lung Transplant. 2022. PMID: 36182652. doi:10.1016/j.healun.2022.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。